Selected Publications
View on Google Scholar →Parathyroid hormone and trabectedin have differing effects on macrophages and stress fracture repair
Zweifler LE, Sinder BP, Stephan C, Koh AJ, Do J, Ulrich E, Jobanpreet G, Woo C, Batoon L, Kozloff KM, Roca H, Mishina Y, McCauley LK. Bone. 2024.
Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype
Sinder BP, Novak S, Wee NKY, Basile M, Maye P, Matthews BG, Kalajzic I. Stem Cells. 2020.
Bone mass is compromised by the chemotherapeutic trabectedin in association with effects on osteoblasts and macrophage efferocytosis
Sinder BP, Zweifler L, Koh AJ, Michalski MN, Hofbauer LC, Aguirre JI, Roca H, McCauley LK. Journal of Bone and Mineral Research. 2017.
Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age
Sinder BP, Lloyd WR, Salemi JD, Marini JC, Caird MS, Morris MD, Kozloff KM. Bone. 2016.
Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
Sinder BP, Salemi JD, Ominsky MS, Caird MS, Marini JC, Kozloff KM. Bone. 2015.